Press release Read more about Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
Press release Read more about Huddlestock Fintech AS has today published the Audited Annual Report for 2023
Press release Read more about Vow ASA: Vow receives payment for Early Production Line at VGM's Hønefoss plant